The store will not work correctly when cookies are disabled.
4-Methoxy-2-(2-(methylthio)imidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzo[d]thiazole
ID: ALA3728053
Chembl Id: CHEMBL3728053
PubChem CID: 89873594
Max Phase: Preclinical
Molecular Formula: C13H10N4OS3
Molecular Weight: 334.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc2sc(-c3cn4nc(SC)sc4n3)nc12
Standard InChI: InChI=1S/C13H10N4OS3/c1-18-8-4-3-5-9-10(8)15-11(20-9)7-6-17-12(14-7)21-13(16-17)19-2/h3-6H,1-2H3
Standard InChI Key: WZBZHHVVXJFVGP-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.45 | Molecular Weight (Monoisotopic): 334.0017 | AlogP: 3.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 52.31 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.72 | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.53 | Np Likeness Score: -2.29 |
References
1. (2013) Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation, |